Peter Attia· MD
well it's really interesting um because the time course of that disease was the time course of that study was so short in a group of patients who were already so heavily statinized that it's my interpretation of that study when it came out which is probably six years ago it's actually a miracle that showed anything at all because if these patients are walking around with an ldlc that's at the fifth percentile of the population and then you give them another agent that lowers ldlc to you know the first percentile of the population and we're talking about a disease that takes at least four decades to take hold and you study them for just five years would you really expect to see an event difference